Variations in the coding and regulatory sequences of the angiogenin (ANG) gene are not associated to ALS (amyotrophic lateral sclerosis) in the Italian population
Introduction
Amyotrophic lateral sclerosis (ALS) is an adult onset neurodegenerative disorder characterized by progressive loss of motor neurons in the spinal cord, brainstem, and cerebral cortex. Five to ten percent of ALS cases are familial (FALS), mostly inherited as autosomal dominant, and 14–24% of them have mutations in the gene encoding for Cu/Zn superoxide dismutase (SOD1). However in the majority of familial and sporadic (SALS) ALS patients, the cause of the selective degeneration of motor neurons is unknown.
Recently a positive association with ALS of the G allele of the synonymous SNP rs11701 in the ANG (angiogenin) gene was identified in the Irish population [1]. Genotyping of rs11701 in 1629 ALS patients and 1264 ethnically matched controls from five populations mostly of Northern Europe origin from Ireland, Scotland, USA Boston, Sweden, UK [2], and in 210 Italian SALS patients and 306 Italian controls [3] confirmed the positive association only in the Irish and Scottish populations. Moreover, sequencing of the ANG coding regions in the same patients identified in 15 ALS patients 7 missense mutations of which only one (K17I) was also detected in a healthy 65-year-old male. Six of these missense mutations affect functionally important residues that are evolutionary highly conserved suggesting a potential causative role in ALS pathogenesis. Sixty percent of the patients with a mutation presented with a bulbar site of onset as against 24–28% in the total tested patients, 4 cases reported a family history of ALS and 12 were of Irish/Scottish origin [2]. No mutation was detected in the Italian patients [3]. Thus ANG mutations appeared to be largely restricted to patients from Irish and/or Scottish ancestry.
In order to confirm and extend the above results we tested the involvement of ANG sequence variations in a further large sample of Italian ALS patients and controls. In addition to what performed in previous studies, we also screened for variations the ANG regulatory sequences and tested the association of all the detected variations with ALS susceptibility and clinical presentation.
Section snippets
Patients and controls
The 262 Italian ALS patients (1.7:1 male:female ratio) included in this study consecutively referred to three ALS centres (Novara, Siena, Milano).
All the patients that were included in the study were classified according to the El Escorial revised criteria [4] as definite, probable and probable laboratory-supported. Possible ALS were excluded because of the uncertainty of the diagnosis. ALS was classified as familial when at least one further member was reported to be clinically affected in the
ANG gene variations
Two-hundred-sixty-two ALS patients and 415 unrelated matched controls were screened for sequence variations in the coding region, intron/exon boundaries, 5′ and 3′ UTR, and the 5′ flanking region (642 bp immediately upstream the transcription start site) of the ANG gene. A total of 53 variations were identified, of which 7 were already reported in the SNP database (http://www.ncbi.nlm.nih.gov/SNP/) and 20 had a minor allele frequency (MAF) ≥ 0.01 either in the patients or in controls or in both (
Discussion
A large sample of Italian patients and controls was screened for sequence variations in the ANG coding and regulative regions.
Only one missense variation (I46V) was identified in one patient and in two controls. The same missense variation was originally included among possible ALS causative mutations because identified in 3 ALS patients and not in 1624 controls [2]. However, as discussed by Greenway et al. [2], it affects a residue that is not fully evolutionary conserved and the substitution
Acknowledgments
This work was supported by grants from Regione Piemonte (Progetto Ricerca Sanitaria Finalizzata bando 2006), Eastern Piedmont University (ex 60%) and the Italian Ministry for University and Research (PRIN2005 to D.S., PRIN2006 to G.F.)
L.B. is a Ph.D. student of Doctorate of Research “Biotechnology for Man Health” and is supported by a fellowship from CRT (Borsa Lagrange).
References (22)
- et al.
SOD1 gene mutations in Italian patients with sporadic amyotrophic lateral sclerosis (ALS)
Neuromuscul Disord
(2006) - et al.
Identification of single nucleotide variations in the coding and regulatory regions of the myelin-associated glycoprotein gene and study of their association with multiple sclerosis
J Neuroimmunol
(2002) - et al.
Another angiogenic gene linked to amyotrophic lateral sclerosis
Trends Mol Med
(2006) - et al.
A novel candidate region for ALS on chromosome 14q11.2
Neurology
(2004) - et al.
ANG mutations segregate with familial and ‘sporadic’ amyotrophic lateral sclerosis
Nat Genet
(2006) - et al.
Absence of angiogenic genes modification in Italian ALS patients
Neurobiol Aging
(2006) Defining optimal management in ALS: from first symptoms to announcement
Neurology
(1999)- et al.
SOD1 mutations in amytrophic lateral sclerosis. Results from a multicentric Italian study
J Neurol
(2005) - et al.
Optimal temperature selection for mutation detection by denaturing HPLC and comparison to single-stranded conformation polymorphism and heteroduplex analysis
Clin Chem
(1999) Amyotrophic lateral sclerosis associated with mutations in the CuZn superoxide dismutase gene
Curr Neurol Neurosci Rep
(2006)